protoporphyrin ix has been researched along with Osteosarcoma in 3 studies
protoporphyrin IX: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7685
protoporphyrin : A cyclic tetrapyrrole that consists of porphyrin bearing four methyl substituents at positions 3, 8, 13 and 17, two vinyl substituents at positions 7 and 12 and two 2-carboxyethyl substituents at positions 2 and 18. The parent of the class of protoporphyrins.
Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We observed that two osteosarcoma cell lines from the same tumor displayed marked differences in their sensitivities to photodynamic therapy (PDT) with aminolevulinic acid hexyl ester (hALA-PDT)." | 7.75 | Synergistic increase in osteosarcoma cell sensitivity to photodynamic therapy with aminolevulinic acid hexyl ester in the presence of hyperthermia. ( Matsumura, Y; Nomura, J; Tagawa, T; Watanabe, Y; Yanase, S, 2009) |
| "We observed that two osteosarcoma cell lines from the same tumor displayed marked differences in their sensitivities to photodynamic therapy (PDT) with aminolevulinic acid hexyl ester (hALA-PDT)." | 3.75 | Synergistic increase in osteosarcoma cell sensitivity to photodynamic therapy with aminolevulinic acid hexyl ester in the presence of hyperthermia. ( Matsumura, Y; Nomura, J; Tagawa, T; Watanabe, Y; Yanase, S, 2009) |
| "In the present study, we have investigated a combination of photodynamic therapy (PDT) using 5-aminolevulinic acid (ALA) and simultaneous hyperthermia (HT) on osteosarcoma (HOSM-1) cells, squamous cell carcinoma (KB) cells and fibroblasts (HF), including an assessment of the differences in the sensitivity of these cells to such treatment in vitro." | 3.73 | Enhancement of the effect of 5-aminolevulinic acid-based photodynamic therapy by simultaneous hyperthermia. ( Kinoshita, M; Matsumura, Y; Nagai, K; Nakanishi, H; Nomura, J; Ohnishi, Y; Tagawa, T; Tokuda, T; Yanase, S, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Makhadmeh, GN | 1 |
| Abdul Aziz, A | 1 |
| Yanase, S | 2 |
| Nomura, J | 2 |
| Matsumura, Y | 2 |
| Watanabe, Y | 1 |
| Tagawa, T | 2 |
| Nagai, K | 1 |
| Kinoshita, M | 1 |
| Nakanishi, H | 1 |
| Ohnishi, Y | 1 |
| Tokuda, T | 1 |
3 other studies available for protoporphyrin ix and Osteosarcoma
| Article | Year |
|---|---|
Photodynamic application of protoporphyrin IX as a photosensitizer encapsulated by silica nanoparticles.
Topics: Bone Neoplasms; Humans; Nanoparticles; Osteosarcoma; Photochemotherapy; Photosensitizing Agents; Pro | 2018 |
Synergistic increase in osteosarcoma cell sensitivity to photodynamic therapy with aminolevulinic acid hexyl ester in the presence of hyperthermia.
Topics: Aminolevulinic Acid; Cell Line, Tumor; Combined Modality Therapy; Humans; Hyperthermia, Induced; Inf | 2009 |
Enhancement of the effect of 5-aminolevulinic acid-based photodynamic therapy by simultaneous hyperthermia.
Topics: Aminolevulinic Acid; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Separation; Ch | 2005 |